Apixaban 13C D3
| Product Name | Apixaban 13C D3 |
|---|---|
| Alternate Names | Apixaban Stable Isotopes, Stable Isotopes of Apixaban |
| CAT No. | CS-O-06410 |
| CAS No. | 1261393-15-0 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 463.51 g/mol |
| Mol. For. | C₂₄¹³CH₂₂D₃N₅O₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Apixaban |
| Purity | Not less than 95 % |
| Therapeutic | Anti-Thrombotics |
| Smileys | COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N |
| Canonical Smiles | COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N |
| InchIKey | QNZCBYKSOIHPEH-KQORAOOSSA-N |
| Inchl | InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)/i1+1D3 |
| IUPAC | 7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1-[4-(trideuterio(113C)methoxy)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Apixaban 13C D3 is a stable isotope labeled version of Apixaban, an oral anticoagulant medication used to reduce the risk of stroke and blood clots in patients with atrial fibrillation, deep vein thrombosis, and pulmonary embolism. The stable isotope labeling allows for precise analysis of the drug's pharmacokinetics, metabolism, and excretion in clinical studies.
The chemical formula of Apixaban 13C D3 is C25H25N5O4S, with a molecular weight of 489.57 g/mol. The labeled carbon atoms (13C) in the drug molecule allow for accurate determination of the drug's fate in the body through techniques such as mass spectrometry.
Apixaban works by inhibiting Factor Xa, a key enzyme in the coagulation cascade. This prevents the formation of blood clots and reduces the risk of stroke and other thromboembolic events. The drug has a half-life of approximately 12 hours and is primarily metabolized by the liver.
Apixaban 13C D3 is used in clinical research to investigate the pharmacokinetics and pharmacodynamics of the drug in various patient populations. It is also used in drug-drug interaction studies to determine how other medications may affect the metabolism and efficacy of Apixaban.
Overall, Apixaban 13C D3 is a valuable tool in drug development and clinical research, providing critical information on the safety and efficacy of Apixaban in patients.
Get an Instant Quote
Related Compounds
Apixaban 13C D7 | Apixaban PG Ester-I d3 | Apixaban Acid-13C | Apixaban PG Ester-II d3 |